News from pharmaceuticals

Is This Beaten-Down Cathie Wood Artificial Intelligence (AI) Stock a Buy?

Jim Cramer on ARS Pharmaceuticals: “It’s a Great Flier”

AstraZeneca taps Chinese biotech in $5.2bn chronic disease research deal

23andMe Re-Opens Data Auction With $305 Million Bid From Former CEO

Rocket Pharmaceuticals, Inc. (RCKT) Gene Therapy Trial Paused Following Patient Death

3 High-Flying Stocks That Could Soar Even More

Prices for new US drugs doubled in 4 years as focus on rare disease grows

Qubit Pharmaceuticals unveil "world's most powerful" quantum AI model

Why ACADIA Pharmaceuticals Inc. (ACAD) Skyrocketed on Friday

Why BioCryst Pharmaceuticals, Inc. (BCRX) Soared on Monday

Trump signs order to boost domestic drug manufacturing as pharma tariff threat looms

Eli Lilly CEO says company can help 'respond' to national security concerns around essential drugs as tariffs loom

Regeneron partners with Fujifilm to broaden manufacturing capacity

Roche to invest $50 billion in the U.S. as pharma tariff threat lingers

Is Supernus Pharmaceuticals, Inc. (SUPN) the Best Pharma Stock to Buy for Long Term Growth?

Analysis-Pharma companies expected to absorb any tariff hit in short term

Why Recursion Pharmaceuticals, Inc. (RXRX) Surged On Friday?

Is Catalyst Pharmaceuticals, Inc. (CPRX) the Best Russell 2000 Stock to Buy According to Wall Street Analysts?

Tonix Pharmaceuticals Corp. (Nasdaq:TNXP) ranks 7th on our list of stocks that fall behind amid market optimism

Trump's proposed pharmaceutical tariffs could drive up costs, lead to drug shortages: Experts

Streams of medicines: what’s hiding in the UK’s waterways? – podcast

EU Commission head discusses U.S. tariff response with auto, steel and pharma executives